Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-11-100611
Filing Date
2011-04-18
Accepted
2011-04-18 12:08:37
Documents
6
Period of Report
2011-05-18
Effectiveness Date
2011-04-18

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 205363
2 GRAPHIC g176457g16g21.jpg GRAPHIC 7974
3 GRAPHIC g176457g47i84.jpg GRAPHIC 61219
4 GRAPHIC g176457g51p54.jpg GRAPHIC 6364
5 GRAPHIC g176457prx_001.jpg GRAPHIC 2083
6 GRAPHIC g176457prx_002.jpg GRAPHIC 2152
  Complete submission text file 0001193125-11-100611.txt   317047
Mailing Address 12325 EMMET STREET OMAHA NE 68164
Business Address 12325 EMMET ST OMAHA NE 68164 4027385480
TRANSGENOMIC INC (Filer) CIK: 0001043961 (see all company filings)

EIN.: 911789357 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30975 | Film No.: 11764885
SIC: 3826 Laboratory Analytical Instruments